Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00156273 · ClinicalTrials.gov registry record
Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 69
- Enrollment target
NCT00156273 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 69 participants.
The verdict
NCT00156273 has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
Study Summary
We are trying to develop better ways to detect when cancer therapies are working.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2005-04 |
| Est. Completion | 2008-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00156273
The ClinicalTrials.gov registry entry for NCT00156273 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00156273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00156273 about?
NCT00156273 is a clinical study titled "Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer". We are trying to develop better ways to detect when cancer therapies are working.
What is the current status of trial NCT00156273?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2005-04. Estimated completion is 2008-10.
Who is sponsoring clinical trial NCT00156273?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.